FSTX
Price:
$7.12
Market Cap:
$156.51M
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing...[Read more]
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
FSTX
According to F-star Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.98. This represents a change of 34.90% compared to the average of 5.18 of the last 4 quarters.
The mean historical Current Ratio of F-star Therapeutics, Inc. over the last ten years is 6.60. The current 6.98 Current Ratio has changed 10.48% with respect to the historical average. Over the past ten years (40 quarters), FSTX's Current Ratio was at its highest in in the June 2017 quarter at 16.16. The Current Ratio was at its lowest in in the December 2019 quarter at 0.64.
Average
6.60
Median
7.14
Minimum
0.64
Maximum
11.61
Discovering the peaks and valleys of F-star Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 354.83%
Maximum Annual Current Ratio = 11.61
Minimum Annual Increase = -94.52%
Minimum Annual Current Ratio = 0.64
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 6.98 | 354.83% |
| 2020 | 1.54 | 141.26% |
| 2019 | 0.64 | -94.52% |
| 2018 | 11.61 | 0.63% |
| 2017 | 11.53 | 57.90% |
The current Current Ratio of F-star Therapeutics, Inc. (FSTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.05
5-year avg
6.46
10-year avg
6.60
F-star Therapeutics, Inc.’s Current Ratio is less than Theseus Pharmaceuticals, Inc. (17.79), less than Selecta Biosciences, Inc. (7.65), greater than eXoZymes, Inc. (1.32), less than Pardes Biosciences, Inc. (9.81), greater than aTyr Pharma, Inc. (5.78), greater than Vaccitech plc (6.05), less than NGM Biopharmaceuticals, Inc. (7.79), greater than Sesen Bio, Inc. (0.86), greater than Paratek Pharmaceuticals, Inc. (3.66), greater than Decibel Therapeutics, Inc. (4.81),
| Company | Current Ratio | Market cap |
|---|---|---|
| 17.79 | $181.50M | |
| 7.65 | $135.20M | |
| 1.32 | $66.39M | |
| 9.81 | $135.19M | |
| 5.78 | $44.17M | |
| 6.05 | $192.73M | |
| 7.79 | $128.53M | |
| 0.86 | $127.96M | |
| 3.66 | $127.83M | |
| 4.81 | $123.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like F-star Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like F-star Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is F-star Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for F-star Therapeutics, Inc. (FSTX)?
What is the highest Current Ratio for F-star Therapeutics, Inc. (FSTX)?
What is the 3-year average Current Ratio for F-star Therapeutics, Inc. (FSTX)?
What is the 5-year average Current Ratio for F-star Therapeutics, Inc. (FSTX)?
How does the current Current Ratio for F-star Therapeutics, Inc. (FSTX) compare to its historical average?